Iperionx Ltd. ADR (IPX)
NASDAQ:IPX
Want to see IPX full AI Analyst Report?
Top Page
Iperionx Ltd. ADR
(NASDAQ:IPX)
Select Model
Select Model
Rating:52Neutral
Price Target:
$35.00
▲(6.45% Upside)
Action:Reiterated
Date:05/08/26
The score is held down primarily by weak financial performance (pre-revenue status, widening losses, and rising cash burn implying continued reliance on external funding). Technicals provide the main support with an established uptrend and positive momentum, while valuation remains constrained by ongoing losses and a non-meaningful negative P/E.
Positive Factors
Domestic critical-minerals anchor: Titan DFS
The Definitive Feasibility Study describes a long-life, near-surface mineral sands operation with proven reserves and government support, underpinning a durable upstream feedstock for U.S. titanium and rare-earth supply chains and strengthening IperionX's strategic role over years.
Negative Factors
Pre-revenue with widening losses
Zero reported revenue and materially larger losses year-over-year indicate the business has yet to prove commercial demand. Persistent operating losses lengthen the path to self-sustaining cash generation, raising execution and dilution risk until sales are established.
Read all positive and negative factors
Positive Factors
Negative Factors
Domestic critical-minerals anchor: Titan DFS
The Definitive Feasibility Study describes a long-life, near-surface mineral sands operation with proven reserves and government support, underpinning a durable upstream feedstock for U.S. titanium and rare-earth supply chains and strengthening IperionX's strategic role over years.
Read all positive factors
Iperionx Ltd. ADR (IPX) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.20B
Dividend YieldN/A
Average Volume (3M)163.91K
Price to Earnings (P/E)―
Beta (1Y)1.78
Revenue GrowthN/A
EPS Growth-48.46%
CountryUS
Employees28
SectorBasic Materials
Sector Strength58
IndustryIndustrial Materials
Share Statistics
EPS (TTM)-10.40
Shares Outstanding33,938,408
10 Day Avg. Volume131,948
30 Day Avg. Volume163,910
Financial Highlights & Ratios
PEG Ratio-1.31
Price to Book (P/B)10.04
Price to Sales (P/S)0.00
P/FCF Ratio-23.55
Enterprise Value/Market Cap1.13
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-507.17
Enterprise Value/Ebitda-18.77
Forecast
1Y Price Target
$58.75Price Target Upside78.68% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-1.11
Revenue Forecast (FY)$3.42M
Iperionx Ltd. ADR Business Overview & Revenue Model
Company Description
IperionX Limited primarily focuses on discovering and developing mineral resource sites. The company's geological surveys seek out valuable deposits, specifically targeting epithermal and replacement-style precious and base metals, alongside titan...
How the Company Makes Money
IperionX’s revenue model is tied to commercializing titanium and critical-mineral products and related processing capabilities. In general, the company aims to generate revenue by (1) selling titanium metal products (e.g., titanium powder and/or o...
Iperionx Ltd. ADR Financial Statement Overview
Summary
Income Statement
8
Very Negative
Balance Sheet
56
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -2.68M | -2.27M | -648.22K | -634.11K | -152.90K | -9.38K |
| EBITDA | -72.49M | -37.79M | -22.49M | -16.86M | -21.64M | -8.82M |
| Net Income | -70.16M | -35.35M | -22.23M | -17.44M | -21.52M | -13.28M |
Balance Sheet | ||||||
| Total Assets | 129.16M | 105.03M | 55.44M | 22.80M | 9.91M | 2.79M |
| Cash, Cash Equivalents and Short-Term Investments | 65.83M | 54.81M | 33.16M | 11.94M | 5.67M | 1.70M |
| Total Debt | 4.46M | 3.93M | 1.49M | 975.31K | 543.03K | 475.65K |
| Total Liabilities | 20.95M | 12.59M | 4.10M | 2.24M | 2.49M | 1.03M |
| Stockholders Equity | 108.20M | 92.44M | 51.34M | 20.56M | 7.42M | 1.76M |
Cash Flow | ||||||
| Free Cash Flow | -53.61M | -39.41M | -26.68M | -18.57M | -14.06M | -3.62M |
| Operating Cash Flow | -18.98M | -21.80M | -18.68M | -15.86M | -12.13M | -3.56M |
| Investing Cash Flow | -18.96M | -24.28M | -6.53M | -5.71M | -3.07M | 1.76M |
| Financing Cash Flow | 925.04K | 67.99M | 46.59M | 27.89M | 19.39M | 3.50M |
Iperionx Ltd. ADR Technical Analysis
Negative
32.88
Price Trends
34.82
Negative
38.60
Negative
40.55
Negative
Market Momentum
0.33
Positive
42.50
Neutral
10.28
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IPX, the sentiment is Negative. The current price of 32.88 is below the 20-day moving average (MA) of 38.25, below the 50-day MA of 34.82, and below the 200-day MA of 40.55, indicating a bearish trend. The MACD of 0.33 indicates Positive momentum. The RSI at 42.50 is Neutral, neither overbought nor oversold. The STOCH value of 10.28 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IPX.
Iperionx Ltd. ADR Risk Analysis
Iperionx Ltd. ADR disclosed 51 risk factors in its most recent earnings report. Iperionx Ltd. ADR reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Iperionx Ltd. ADR Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | $4.53B | -9.59 | -76.51% | ― | ― | -493.47% | |
53 Neutral | $1.02B | -60.04 | -16.94% | ― | 104.34% | -1352.44% | |
52 Neutral | $1.20B | -32.30 | -35.30% | ― | ― | -48.46% | |
51 Neutral | $9.52B | -133.39 | -3.49% | ― | 60.93% | 34.20% | |
48 Neutral | $711.94M | -6.45 | -15.03% | 1.17% | -11.77% | -85.76% |
* Basic Materials Sector Average
IPX
Iperionx Ltd. ADR
34.19
6.05
21.50%
GSM
Ferroglobe
3.81
-0.07
-1.93%
UAMY
United States Antimony
6.86
3.83
126.40%
MP
MP Materials
53.45
27.81
108.46%
CRML
Critical Metals Corp
9.17
7.76
550.35%
USAR
USA Rare Earth
20.33
7.88
63.29%
Iperionx Ltd. ADR Corporate Events
IperionX DFS Confirms High-Return Titan Critical Minerals Project in Tennessee
Jun 4, 2026
On June 4, 2026, IperionX released the Definitive Feasibility Study for its 100%-owned Titan Critical Minerals Project near Camden, Tennessee, confirming a large-scale, near-surface mineral sands operation producing titanium minerals, zircon and a...
IperionX Files Titan Project Feasibility Technical Report with U.S. SEC
Jun 4, 2026
IperionX Limited, a foreign private issuer headquartered in South Boston, Virginia, has filed a Form 6-K with the U.S. Securities and Exchange Commission dated June 4, 2026, to lodge a Technical Report Summary for its Titan Project in Tennessee. T...
IperionX Commissions Advanced SACMI Press to Triple U.S. Titanium Output
May 21, 2026
On May 21, 2026, IperionX Limited announced it has commissioned a 300-ton, six-axis SACMI powder metallurgy press at its Titanium Manufacturing Campus in South Boston, Virginia. The system uses titanium powder from the company’s HAMR process...
IperionX Files December 2025 Half‑Year Results, Revealing Wider Interim Loss
Mar 12, 2026
On March 12, 2026, IperionX Limited filed a Form 6‑K with the U.S. Securities and Exchange Commission, lodging its unaudited condensed consolidated financial statements for the six months ended December 31, 2025, alongside its ASX half‑...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.